Abstract
METHODS:
The expression of VEGF, TGF-β 1 , MMP-2 and MMP-9 was measured by immunohistochemical S-P method in 45 cases of primary epithelial ovarian carcinoma and 38 cases of Krukenberg tumor.
RESULTS:
The positive rates of VEGF and TGF-β 1 expression were significantly higher in the tissues of primary epithelial ovarian carcinoma and Krukenberg tumor than those in the normal ovarian tissues (VEGF: χ 2 = 5.318, P = 0.021; χ 2 = 22.985, P = 0.001; TGFβ 1 : χ 2 = 9.778, P = 0.002; χ 2 = 12.584, P = 0.001). The positive rates of MMP-2 and MMP-9 expression were zero in the normal ovarian tissues. The expressions of VEGF, MMP-2 and MMP-9 were remarkably higher in the Krukenberg tumor than those in the primary epithelial ovarian carcinoma (χ 2 = 13.149, P = 0.001; χ 2 = 33.668, P = 0.001; χ 2 = 38.839, P = 0.001). The positive expression of TGF-β 1 was not significantly different between tissues of primary epithelial ovarian carcinoma and Krukenberg tumor. The expression of VEGF, TGF-β1, MMP-2 and MMP-9 positively correlated with one another in primary epithelial ovarian carcinoma and Krukenberg tumor (P <0.05 or P <0.01).
CONCLUSION: VEGF, TGF-β1, MMP-2 and MMP-9 play important roles in the carcinogenesis and development of ovarian carcinoma and Krukenberg tumor. They may provide evidence for the differential diagnosis between the two diseases. 
